Form 4 for BIIB Biogen
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-10 · accession 0001127602-23-005269 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-14 | 2023-02-10 | BIIB | MCDONNELL MICHAEL R | EVP, CFO | M - OptEx | $0.00 | +3,256 | 10.0K | +48% | $0 |
| D | 2023-02-14 | 2023-02-10 | BIIB | MCDONNELL MICHAEL R | EVP, CFO | F - Tax | $286.30 | -1,105 | 8,896 | -11% | -$316.4K |
| D | 2023-02-14 | 2023-02-10 | BIIB | MCDONNELL MICHAEL R | EVP, CFO | M - OptEx | $0.00 | -3,256 | 6,514 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-10 | M | A | 3,256 | $0.00 | 10,001 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-10 | F | D | 1,105 | $286.30 | 8,896 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2023-02-10 | M | D | 3,256 | $0.00 | 6,514 | D | $0.00 · — to 2025-02-10 | 3,256 Common Stock | (F1) The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022. |